Partnering

More Topics
Data
Innovation
To protect the future of healthcare, we need to be data-drivenTo protect the future of healthcare, we need to be data-driven

Better data equals better solutions said panelists at LSX Nordics Congress, but collaborations must create behavioral changes to drive innovation.

byMillie Nelson, Editor
Dec 4, 2024
|
1 Min Read
Currency
Investment
Eyes on Asia: Merck and BioNTech land Chinese bispecificsEyes on Asia: Merck and BioNTech land Chinese bispecifics
byRichard Daverman
Dec 4, 2024
1 Min Read
The ELA'S 2024
Innovation
LSX awards the crème de la crème of dealmakingLSX awards the crème de la crème of dealmaking
byMillie Nelson
Dec 3, 2024
1 Min Read
M&A note
Investment
Novartis chases muscular dystrophy treatment with Kate Tx buyNovartis chases muscular dystrophy treatment with Kate Tx buy
byMillie Nelson
Nov 27, 2024
1 Min Read
A whiteboard saying transition
Investment
From Series A to B: Navigating the transition from promise to proofFrom Series A to B: Navigating the transition from promise to proof
byMillie Nelson
Nov 20, 2024
1 Min Read
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturnPicky pharma prone to better proven partners amid dealmaking downturn
byMillie Nelson
Nov 19, 2024
1 Min Read
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Nov 18, 2024
|
1 Min Read
byRichard Daverman, Editor
Panelists Anta Gkelou Partner, Sofinnova Partners; Bobby Soni CIO, BioInnovation Institute; Renee Lucander CEO, Calliditas Therapeutics
Partnering
Successful mentorship between investors and CEOs hangs on respect
Successful mentorship between investors and CEOs hangs on respect
Nov 15, 2024
|
1 Min Read
headshot Stefano Cottignoli, senior vice president and head of global business and development at Chiesi
Partnering
Chiesi’s partnering success: Confessions of a mid-sized pharma
Chiesi’s partnering success: Confessions of a mid-sized pharma
Nov 14, 2024
|
1 Min Read
Money
Investment
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
Nov 5, 2024
|
1 Min Read
byRichard Daverman, Editor
Reverse arrow
Partnering
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
Oct 31, 2024
|
1 Min Read
byRichard Daverman, Editor
Alzheimer's disease written in blocks
Partnering
AbbVie forks out $1.4bn to buy Alzheimer’s therapy developer Aliada
AbbVie forks out $1.4bn to buy Aliada
Oct 29, 2024
|
1 Min Read
byMillie Nelson, Editor
Investment
What’s your secret sauce? VC’s on what makes a compelling pitch
VC’s on what makes a compelling pitch
Oct 24, 2024
|
1 Min Read
byMillie Nelson, Editor
Asian currency
Innovation
Eyes on Asia: Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
Oct 21, 2024
|
1 Min Read
byRichard Daverman, Editor
Green leaf with sustainability symbol
Business Strategy
The sustainability series: Reflect, rethink, and reform
The sustainability series: Reflect, rethink, and reform
Oct 11, 2024
|
1 Min Read
byMillie Nelson, Editor
Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Oct 1, 2024
|
1 Min Read
byMillie Nelson, Editor
Hubs
Eyes on Asia: News from Sanofi, Bayer, AZ plus the return of VC?
News from Sanofi, Bayer, AZ plus the return of VC?
Sep 29, 2024
|
1 Min Read
byRichard Daverman, Editor
Wooden block with people icons
Partnering
Want to be a partner of choice? Distinguish yourself in the space
Want to be a partner of choice? Distinguish yourself in the space
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
Partnering
To be truly great you need to partner, says J&J
To be truly great you need to partner, says J&J
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
Christmas present
Partnering
RayzeBio: A Christmas to remember
RayzeBio: A Christmas to remember
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
People making business deals
Partnering
Prometheus and Merck: Under the bonnet of the largest pre-Phase III M&A deal
Under the bonnet of the largest pre-Phase III M&A deal
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
Oncology
Partnering
Bayer and NextRNA: One partnership, two oncology programs
Bayer and NextRNA: One partnership, two oncology programs
Sep 25, 2024
|
1 Min Read
byMillie Nelson, Editor
Hubs
Eyes on Asia: Shinyaku’s $735m DMD deal, Kite turns back in China, and more
Shinyaku’s $735m DMD deal, Kite turns back in China, and more
Sep 23, 2024
|
1 Min Read
byRichard Daverman, Editor
Chinese flag — Photo
Investment
China biopharma faces a pause; how bad is it?
China biopharma mid-2023 market summary
Sep 21, 2024
|
1 Min Read
byRichard Daverman, Editor
Illustration, Science word. Business concept for Study of physical world structure behavior Experimental research — Illustration
Innovation
European drug discovery and development players showcase their science at BIO-Europe 2023
European drug discovery and development players showcase their science
Sep 21, 2024
|
1 Min Read
photo of panel at BIO Europe Spring 2024
Partnering
Moving from eminence-based to evidence-based healthcare
Moving from eminence-based to evidence-based healthcare
Sep 19, 2024
|
1 Min Read
Investment
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Sep 18, 2024
|
1 Min Read
byRichard Daverman, Editor
Partnering
Top five Asia biopharma deals: August 2024
Asia biopharma deals: August 2024
Sep 15, 2024
|
1 Min Read
byRichard Daverman, Editor
Partnering
Eyes on Asia: EpimAb sells T-cell, funding for TargetRx, Hygieai on the siRNA march
Eyes on Asia: News from EpimAb, TargetRx, Hygieai
Sep 7, 2024
|
1 Min Read
byRichard Daverman, Editor
Innovation
Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz
Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz
Sep 1, 2024
|
1 Min Read
byRichard Daverman, Editor
Investment
Eyes on Asia: Mulititude out licenses, Huadong bulks up Abs, Merck and Kelun
Eyes on Asia: Multitude out licenses, Huadong bulks up Abs, Merck and Kelun
Aug 25, 2024
|
1 Min Read
byRichard Daverman, Editor
Abu Dhabi Global Healthcare Week 2024
Partnering
BioNTech: Partnerships are key to deliver drugs at scale
BioNTech: Partnerships are key to deliver drugs at scale
May 20, 2024
|
1 Min Read
byMillie Nelson, Editor
different coloured smoke
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
1 Min Read
byMillie Nelson, Editor
Wedding rings
Partnering
Perfect match: Picking your CDMO is like a marriage, says Bayer
Picking your CDMO is like a marriage, says Bayer
Apr 11, 2024
|
1 Min Read
byMillie Nelson, Editor
BIO-Europe Spring
Partnering
Competitor today, friend tomorrow: Why partnering is critical for biopharma success
Why partnering is critical for biopharma success
Apr 5, 2024
|
1 Min Read
byMillie Nelson, Editor

News from APAC

Currency
Investment
Eyes on Asia: Merck and BioNTech land Chinese bispecificsEyes on Asia: Merck and BioNTech land Chinese bispecifics
byRichard Daverman
Dec 4, 2024
4 Min Read
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blastEyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
byRichard Daverman
Nov 18, 2024
5 Min Read
Money
Investment
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScriptEyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
byRichard Daverman
Nov 5, 2024
3 Min Read
Jan 13 - Jan 15, 2025
An all-inclusive healthcare conference at Hilton Union Square, San Francisco
Register

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated